Skip to main content
SpringerLink
Log in

Myricetin inhibits proliferation and induces apoptosis and cell cycle arrest in gastric cancer cells

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Myricetin is a flavonoid that is abundant in fruits and vegetables and has protective effects against cancer and diabetes. However, the mechanism of action of myricetin against gastric cancer (GC) is not fully understood. We researched myricetin on the proliferation, apoptosis, and cell cycle in GC HGC-27 and SGC7901 cells, to explore the underlying mechanism of action. Cell Counting Kit (CCK)-8 assay, Western blotting, cell cycle analysis, and apoptosis assay were used to evaluate the effects of myricetin on cell proliferation, apoptosis, and the cell cycle. To analyze the binding properties of ribosomal S6 kinase 2 (RSK2) with myricetin, surface plasmon resonance (SPR) analysis was performed. CCK8 assay showed that myricetin inhibited GC cell proliferation. Flow cytometry analysis showed that myricetin induces apoptosis and cell cycle arrest in GC cells. Western blotting indicated that myricetin influenced apoptosis and cell cycle arrest of GC cells by regulating related proteins. SPR analysis showed strong binding affinity of RSK2 and myricetin. Myricetin bound to RSK2, leading to increased expression of Mad1, and contributed to inhibition of HGC-27 and SGC7901 cell proliferation. Our results suggest the therapeutic potential of myricetin in GC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893–2917

    Article  CAS  PubMed  Google Scholar 

  2. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60:277–300

    Article  PubMed  Google Scholar 

  3. Crew KD, Neugut AI (2006) Epidemiology of gastric cancer. World J Gastroenterol 12:354–362

    PubMed Central  PubMed  Google Scholar 

  4. Weng CJ, Yen GC (2012) Flavonoids, a ubiquitous dietary phenolic subclass, exert extensive in vitro anti-invasive and in vivo anti-metastatic activities. Cancer Metastasis Rev 31:323–351

    Article  CAS  PubMed  Google Scholar 

  5. López-Lázaro M, Willmore E, Austin CA (2010) The dietary flavonoids myricetin and fisetin act as dual inhibitors of DNA topoisomerases I and II in cells. Mutat Res 696:41–47

    Article  PubMed  Google Scholar 

  6. Frödin M, Jensen CJ, Merienne K, Gammeltoft S (2000) A phosphoserine-regulated docking site in the protein kinase RSK2 that recruits and activates PDK1. EMBO J 19:2924–2934

    Article  PubMed Central  PubMed  Google Scholar 

  7. Artamonov M, Momotani K, Utepbergenov D, Franke A, Khromov A, Derewenda ZS, Somlyo AV (2013) The p90 ribosomal S6 kinase (RSK) is a mediator of smooth muscle contractility. PLoS ONE 8:e58703

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. Yoon S, Seger R (2006) The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors 24:21–44

    Article  CAS  PubMed  Google Scholar 

  9. Rubinfeld H, Seger R (2005) The ERK cascade: a prototype of MAPK signaling. Mol Biotechnol 31:151–174

    Article  CAS  PubMed  Google Scholar 

  10. Yong HY, Koh MS, Moon A (2009) The p38 MAPK inhibitors for the treatment of inflammatory diseases and cancer. Expert Opin Investig Drugs 18:1893–1905

    Article  CAS  PubMed  Google Scholar 

  11. Meyuhas O (2008) Physiological roles of ribosomal protein S6: one of its kinds. Int Rev Cell Mol Biol 268:1–37

    Article  CAS  PubMed  Google Scholar 

  12. Zang W, Wang T, Wang Y, Li M, Xuan X, Ma Y, Du Y, Liu K, Dong Z, Zhao G (2014) Myricetin exerts anti- proliferative, anti-invasive, and pro-apoptotic effects on esophageal carcinoma EC9706 and KYSE30 cells via RSK2. Tumor Biol 35:12583–12592

    Article  CAS  Google Scholar 

  13. Ren W, Qiao Z, Wang H, Zhu L, Zhang L (2003) Flavonoids: promising anticancer agents. Med Res Rev 23:519–534

    Article  CAS  PubMed  Google Scholar 

  14. Galati G, O’Brien PJ (2004) Potential toxicity of flavonoids and other dietary phenolics: significance for their chemopreventive and anticancer properties. Free Radic Biol Med 37:287–303

    Article  CAS  PubMed  Google Scholar 

  15. Kuntz S, Wenzel U, Daniel H (1999) Comparative analysis of the effects of flavonoids on proliferation, cytotoxicity, and apoptosis in human colon cancer cell lines. Eur J Nutr 38:133–142

    Article  CAS  PubMed  Google Scholar 

  16. Jung SK, Lee KW, Byun S, Kang NJ, Lim SH, Heo YS, Bode AM, Bowden GT, Lee HJ, Dong Z (2008) Myricetin suppresses UVB-induced skin cancer by targeting Fyn. Cancer Res 68:6021–6029

    Article  CAS  PubMed  Google Scholar 

  17. Rodgers EH, Grant MH (1998) The effect of the flavonoids, quercetin, myricetin and epicatechin on the growth and enzyme activities of MCF7 human breast cancer cells. Chem Biol Interact 116:213–228

    Article  CAS  PubMed  Google Scholar 

  18. Maggiolini M, Recchia AG, Bonofiglio D, Catalano S, Vivacqua A, Carpino A, Rago V, Rossi R, Andò S (2005) The red wine phenolics piceatannol and myricetin act as agonists for estrogen receptor alpha in human breast cancer cells. J Mol Endocrinol 35:269–281

    Article  CAS  PubMed  Google Scholar 

  19. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674

    Article  CAS  PubMed  Google Scholar 

  20. Molinari M (2000) Cell cycle checkpoints and their inactivation inhuman cancer. Cell Prolif 33:261–274

    Article  CAS  PubMed  Google Scholar 

  21. Choi EJ, Ahn WS (2008) Kaempferol induced the apoptosis via cell cycle arrest in human breast cancer MDA-MB-453 cells. Nutr Res Pract 2:322–325

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  22. Anjum R, Blenis J (2008) The RSK family of kinases: emerging roles in cellular signalling. Nat Rev Mol Cell Biol 9:747–758

    Article  CAS  PubMed  Google Scholar 

  23. Gawecka JE, Young-Robbins SS, Sulzmaier FJ, Caliva MJ, Heikkilä MM, Matter ML, Ramos JW (2012) RSK2 protein suppresses integrin activation and fibronectin matrix assembly and promotes cell migration. J Biol Chem 287:43424–43437

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  24. van Jaarsveld MT, Blijdorp IC, Boersma AW, Pothof J, Mathijssen RH, Verweij J, Wiemer EA (2013) The kinase RSK2 modulates the sensitivity of ovarian cancer cells to cisplatin. Eur J Cancer 49:345–351

    Article  PubMed  Google Scholar 

  25. Eisinger-Mathason TS, Andrade J, Lannigan DA (2010) RSK in tumorigenesis: connections to steroid signaling. Steroids 75:191–202

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  26. Hilinski MK, Mrozowski RM, Clark DE, Lannigan DA (2012) Analogs of the RSK inhibitor SL0101: optimization of in vitro biological stability. Bioorg Med Chem Lett 22:3244–3247

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  27. Lu W, Liu X, Cao X, Xue M, Liu K, Zhao Z, Shen X, Jiang H, Xu Y, Huang J, Li H (2011) SHAFTS: a hybrid approach for 3D molecular similarity calculation. 2. Prospective case study in the discovery of diverse p90 ribosomal S6 protein kinase 2 inhibitors to suppress cell migration. J Med Chem 54:3564–3574

    Article  CAS  PubMed  Google Scholar 

  28. Peng C, Zhu F, Wen W, Yao K, Li S, Zykova T, Liu K, Li X, Ma WY, Bode AM, Dong Z (2012) Tumor necrosis factor receptor-associated factor family protein 2 is a key mediator of the epidermal growth factor-induced ribosomal S6 kinase 2/cAMP responsive element-binding protein/Fos protein signaling pathway. J Biol Chem 287:25881–25892

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  29. Malakhova M, Kurinov I, Liu K, Zheng D, D’Angelo I, Shim JH, Steinman V, Bode AM, Dong Z (2009) Structural diversity of the active N-terminal kinase domain of p90ribosomal S6 kinase 2. PLoS One 4:e8044

    Article  PubMed Central  PubMed  Google Scholar 

  30. Rottmann S, Lüscher B (2006) The Mad side of the Max network: antagonizing the function of Myc and more. Curr Top Microbiol Immunol 302:63–122

    CAS  PubMed  Google Scholar 

  31. Vigneron S, Brioudes E, Burgess A, Labbé JC, Lorca T, Castro A (2010) RSK2 is a kinetochore-associated protein that participates in the spindle assembly checkpoint. Oncogene 29:3566–3574

    Article  CAS  PubMed  Google Scholar 

  32. Bonni A, Brunet A, West AE, Datta SR, Takasu MA, Greenberg ME (1999) Cell survival promoted by the Ras-MAPK signaling pathway by transcription -dependent and -independent mechanisms. Science 286:1358–1362

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Author notes

    Authors and Affiliations

    1. Medical College of Henan University of Science and Technology, Luoyang, 471003, China

      Jianfang Feng

    2. College of Basic Medical Sciences, Zhengzhou University, No. 100 Kexue Road, Zhengzhou, 450001, Henan, China

      Xiaonan Chen, Yuanyuan Wang, Yuwen Du, Qianqian Sun, Wenqiao Zang & Guoqiang Zhao

    Authors
    1. Jianfang Feng
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Xiaonan Chen
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Yuanyuan Wang
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. Yuwen Du
      View author publications

      You can also search for this author in PubMed Google Scholar

    5. Qianqian Sun
      View author publications

      You can also search for this author in PubMed Google Scholar

    6. Wenqiao Zang
      View author publications

      You can also search for this author in PubMed Google Scholar

    7. Guoqiang Zhao
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding author

    Correspondence to Guoqiang Zhao.

    Additional information

    Jianfang Feng and Xiaonan Chen have contributed equally to this work.

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Feng, J., Chen, X., Wang, Y. et al. Myricetin inhibits proliferation and induces apoptosis and cell cycle arrest in gastric cancer cells. Mol Cell Biochem 408, 163–170 (2015). https://doi.org/10.1007/s11010-015-2492-1

    Download citation

    • Received:

    • Accepted:

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s11010-015-2492-1

    Keywords

    Search

    Navigation